The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Vaccine Adjuvants: Putting Innate Immunity to Work
Open accessAbstract
Adjuvants enhance immunity to vaccines and experimental antigens by a variety of mechanisms. In the past decade, many receptors and signaling pathways in the innate immune system have been defined and these innate responses strongly influence the adaptive immune response. The focus of this review is to delineate the innate mechanisms by which adjuvants mediate their effects. We highlight how adjuvants can be used to influence the magnitude and alter the quality of the adaptive response in order to provide maximum protection against specific pathogens. Despite the impressive success of currently approved adjuvants for generating immunity to viral and bacterial infections, there remains a need for improved adjuvants that enhance protective antibody responses, especially in populations that respond poorly to current vaccines. However, the larger challenge is to develop vaccines that generate strong T cell immunity with purified or recombinant vaccine antigens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304
Pattern Recognition Receptors and Inflammation
Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
Toll-like receptor control of the adaptive immune responses
Iwasaki, A., & Medzhitov, R. (2004) · Nature Immunology · doi:10.1038/ni1112 · Cited by 4,193
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H., & Bauer, S. (2004) · Science · doi:10.1126/science.1093620 · Cited by 3,947
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
Kato, H., Takeuchi, O., Sato, S., Yoneyama, M., Yamamoto, M., Matsui, K., Uematsu, S., Jung, A., Kawai, T., Ishii, K. J., et al. (2006) · Nature · doi:10.1038/nature04734 · Cited by 3,888 · cited 4×
“Synthetic analogs of dsRNA (i.e., Poly IC) have been used as adjuvants (Longhi et al., 2009; Stahl-Hennig et al., 2009; Trumpfheller et al., 2008) and can act through two distinct types of PRRs. Viral or synthetic dsRNA activates TLR3 in endosomes (Alexopoulou et al., 2001) or through cytosolic ribonucleic acid (RNA)…”
BackgroundInfluentialInnate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444
Hornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065
Cancer immunotherapy: moving beyond current vaccines
Rosenberg, S. A., Yang, J. C., & Restifo, N. P. (2004) · Nature Medicine · doi:10.1038/nm1100 · Cited by 2,972
Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway
Hemmi, H., Kaisho, T., Takeuchi, O., Sato, S., Sanjo, H., Hoshino, K., Horiuchi, T., Tomizawa, H., Takeda, K., & Akira, S. (2002) · Nature Immunology · doi:10.1038/ni758 · Cited by 2,522
The Inflammasomes: Guardians of the Body
Martinon, F., Mayor, A., & Tschopp, J. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132715 · Cited by 2,436
Regulation of Adaptive Immunity by the Innate Immune System
Iwasaki, A., & Medzhitov, R. (2010) · Science · doi:10.1126/science.1183021 · Cited by 2,157
Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells
Pasare, C., & Medzhitov, R. (2003) · Science · doi:10.1126/science.1078231 · Cited by 1,997
Kadowaki, N., Ho, S., Antonenko, S., de Waal Malefyt, R., Kastelein, R. A., Bazan, F., & Liu, Y.-J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.863 · Cited by 1,964 · cited 6×
“TLR3mediates its effects through the adaptor TRIF (Alexopoulou et al., 2001), whereas RLR signal through the adaptor IFN-B promoter stimulatory-1 (Kato et al., 2006).”
BackgroundInfluentialRecognition of single-stranded RNA viruses by Toll-like receptor 7
Lund, J. M., Alexopoulou, L., Sato, A., Karow, M., Adams, N. C., Gale, N. W., Iwasaki, A., & Flavell, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400937101 · Cited by 1,861
Correlates of protection induced by vaccination
Plotkin, S. A. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00131-10 · Cited by 1,745 · cited 2×
“Most current vaccines confer protection primarily through humoral immunity (Plotkin, 2010).”
BackgroundThe Instructive Role of Innate Immunity in the Acquired Immune Response
Fearon, D. T., & Locksley, R. M. (1996) · Science · doi:10.1126/science.272.5258.50 · Cited by 1,719
Kato, H., Takeuchi, O., Mikamo-Satoh, E., Hirai, R., Kawai, T., Matsushita, K., Hiiragi, A., Dermody, T. S., Fujita, T., & Akira, S. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080091 · Cited by 1,599
Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
Eisenbarth, S. C., Colegio, O. R., O’Connor, W., Sutterwala, F. S., & Flavell, R. A. (2008) · Nature · doi:10.1038/nature06939 · Cited by 1,542
Cooperation of Toll-like receptor signals in innate immune defence
Trinchieri, G., & Sher, A. (2007) · Nature Reviews Immunology · doi:10.1038/nri2038 · Cited by 1,364
Self-citationIntracellular Toll-like Receptors
Blasius, A. L., & Beutler, B. (2010) · Immunity · doi:10.1016/j.immuni.2010.03.012 · Cited by 1,325
Duration of Humoral Immunity to Common Viral and Vaccine Antigens
Amanna, I. J., Carlson, N. E., & Slifka, M. K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066092 · Cited by 1,286
Induction of Dendritic Cell Differentiation by IFN-α in Systemic Lupus Erythematosus
Blanco, P., Palucka, A. K., Gill, M., Pascual, V., & Banchereau, J. (2001) · Science · doi:10.1126/science.1064890 · Cited by 1,266
Mascola, J. R., Stiegler, G., VanCott, T. C., Katinger, H., Carpenter, C. B., Hanson, C. E., Beary, H., Hayes, D., Frankel, S. S., Birx, D. L., et al. (2000) · Nature Medicine · doi:10.1038/72318 · Cited by 1,250
Jongbloed, S. L., Kassianos, A. J., McDonald, K. J., Clark, G. J., Ju, X., Angel, C. E., Chen, C.-J. J., Dunbar, P. R., Wadley, R. B., Jeet, V., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092140 · Cited by 1,027
Kool, M., Soullié, T., van Nimwegen, M., Willart, M. A. M., Muskens, F., Jung, S., Hoogsteden, H. C., Hammad, H., & Lambrecht, B. N. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071087 · Cited by 993
Toll-like receptor 3 promotes cross-priming to virus-infected cells
Schulz, O., Diebold, S. S., Chen, M., Näslund, T. I., Nolte, M. A., Alexopoulou, L., Azuma, Y.-T., Flavell, R. A., Liljeström, P., & Reis e Sousa, C. (2005) · Nature · doi:10.1038/nature03326 · Cited by 921
The Vaccine Adjuvant Monophosphoryl Lipid A as a TRIF-Biased Agonist of TLR4
Mata-Haro, V., Cekic, C., Martin, M., Chilton, P. M., Casella, C. R., & Mitchell, T. C. (2007) · Science · doi:10.1126/science.1138963 · Cited by 896
Towards an understanding of the adjuvant action of aluminium
Marrack, P., McKee, A. S., & Munks, M. W. (2009) · Nature Reviews Immunology · doi:10.1038/nri2510 · Cited by 887
Stoute, J. A., Slaoui, M., Heppner, D. G., Momin, P., Kester, K. E., Desmons, P., Wellde, B. T., Garçon, N., Krzych, U., Marchand, M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360202 · Cited by 870 · cited 1×
“Initial studies showed that RTS,S administered with alum elicited circumsporozoite-specific antibody, but did not confer protection (Stoute et al., 1997).”
ResultBeutler, B. A. (2009) · Blood · doi:10.1182/blood-2008-07-019307 · Cited by 840
Toll-dependent selection of microbial antigens for presentation by dendritic cells
Blander, J. M., & Medzhitov, R. (2006) · Nature · doi:10.1038/nature04596 · Cited by 840
Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848
Jurk, M., Heil, F., Vollmer, J., Schetter, C., Krieg, A. M., Wagner, H., Lipford, G., & Bauer, S. (2002) · Nature Immunology · doi:10.1038/ni0602-499 · Cited by 838
Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle
Ishikawa, E., Ishikawa, T., Morita, Y. S., Toyonaga, K., Yamada, H., Takeuchi, O., Kinoshita, T., Akira, S., Yoshikai, Y., & Yamasaki, S. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20091750 · Cited by 792
Jarrossay, D., Napolitani, G., Colonna, M., Sallusto, F., & Lanzavecchia, A. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200111)31:11<3388::aid-immu3388>3.0.co;2-q · Cited by 788
Didierlaurent, A. M., Morel, S., Lockman, L., Giannini, S. L., Bisteau, M., Carlsen, H., Kielland, A., Vosters, O., Vanderheyde, N., Schiavetti, F., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901474 · Cited by 758
Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells
Bedoui, S., Whitney, P. G., Waithman, J., Eidsmo, L., Wakim, L., Caminschi, I., Allan, R. S., Wojtasiak, M., Shortman, K., Carbone, F. R., et al. (2009) · Nature Immunology · doi:10.1038/ni.1724 · Cited by 715
Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome
Iyer, S. S., Pulskens, W. P., Sadler, J. J., Butter, L. M., Teske, G. J., Ulland, T. K., Eisenbarth, S. C., Florquin, S., Flavell, R. A., Leemans, J. C., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908698106 · Cited by 691
Synthetic TLR Agonists Reveal Functional Differences between Human TLR7 and TLR8
Gorden, K. B., Gorski, K. S., Gibson, S. J., Kedl, R. M., Kieper, W. C., Qiu, X., Tomai, M. A., Alkan, S. S., & Vasilakos, J. P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.3.1259 · Cited by 683
(1992) · International Journal of Biochemistry · doi:10.1016/0020-711x(92)90281-5 · Cited by 671
Poulin, L. F., Salio, M., Griessinger, E., Anjos-Afonso, F., Craciun, L., Chen, J.-L., Keller, A. M., Joffre, O., Zelenay, S., Nye, E., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092618 · Cited by 671
Longhi, M. P., Trumpfheller, C., Idoyaga, J., Caskey, M., Matos, I., Kluger, C., Salazar, A. M., Colonna, M., & Steinman, R. M. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090247 · Cited by 663
Evasion of intracellular host defence by hepatitis C virus
Gale, M., & Foy, E. M. (2005) · Nature · doi:10.1038/nature04078 · Cited by 633
Spörri, R., & Reis e Sousa, C. (2005) · Nature Immunology · doi:10.1038/ni1162 · Cited by 626
Functional Specializations of Human Epidermal Langerhans Cells and CD14+ Dermal Dendritic Cells
Klechevsky, E., Morita, R., Liu, M., Cao, Y., Coquery, S., Thompson-Snipes, L., Briere, F., Chaussabel, D., Zurawski, G., Palucka, A. K., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.07.013 · Cited by 619
Inflammatory signals in dendritic cell activation and the induction of adaptive immunity
Joffre, O., Nolte, M. A., Spörri, R., & Sousa, C. R. E. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00718.x · Cited by 598
Adjuvant-Enhanced Antibody Responses in the Absence of Toll-Like Receptor Signaling
Gavin, A. L., Hoebe, K., Duong, B., Ota, T., Martin, C., Beutler, B., & Nemazee, D. (2006) · Science · doi:10.1126/science.1135299 · Cited by 581
Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant
Casella, C. R., & Mitchell, T. C. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8228-6 · Cited by 560
Querec, T., Bennouna, S., Alkan, S., Laouar, Y., Gorden, K., Flavell, R., Akira, S., Ahmed, R., & Pulendran, B. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051720 · Cited by 552
Kester, K. E., Cummings, J. F., Ofori‐Anyinam, O., Ockenhouse, C. F., Krzych, U., Moris, P., Schwenk, R., Nielsen, R. A., Debebe, Z., Pinelis, E., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/600120 · Cited by 524
Heil, F., Ahmad‐Nejad, P., Hemmi, H., Hochrein, H., Ampenberger, F., Gellert, T., Dietrich, H., Lipford, G., Takeda, K., Akira, S., et al. (2003) · European Journal of Immunology · doi:10.1002/eji.200324238 · Cited by 518
Schoenen, H., Bodendorfer, B., Hitchens, K., Manzanero, S., Werninghaus, K., Nimmerjahn, F., Agger, E. M., Stenger, S., Andersen, P., Ruland, J., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904013 · Cited by 492
Molecular and cellular signatures of human vaccine adjuvants
Mosca, F., Tritto, E., Muzzi, A., Monaci, E., Bagnoli, F., Iavarone, C., O'Hagan, D., Rappuoli, R., & De Gregorio, E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804699105 · Cited by 492
Davis, I. D., Chen, W., Jackson, H., Parente, P., Shackleton, M., Hopkins, W., Chen, Q., Dimopoulos, N., Luke, T., Murphy, R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403572101 · Cited by 440
Seubert, A., Monaci, E., Pizza, M., O’Hagan, D. T., & Wack, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.8.5402 · Cited by 430
New adjuvants for human vaccines
Mbow, M. L., De Gregorio, E., Valiante, N. M., & Rappuoli, R. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.04.004 · Cited by 406
Tighe, H., Takabayashi, K., Schwartz, D., Van Nest, G., Tuck, S., Eiden, J. J., Kagey-Sobotka, A., Creticos, P. S., Lichtenstein, L. M., Spiegelberg, H. L., et al. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.107927 · Cited by 385
Hou, B., Reizis, B., & DeFranco, A. L. (2008) · Immunity · doi:10.1016/j.immuni.2008.05.016 · Cited by 363
Le Bon, A., Thompson, C., Kamphuis, E., Durand, V., Rossmann, C., Kalinke, U., & Tough, D. F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2074 · Cited by 361
Mechanism of action of clinically approved adjuvants
Lambrecht, B. N., Kool, M., Willart, M. A., & Hammad, H. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.01.004 · Cited by 354
Qureshi, N., Takayama, K., & Ribi, E. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33836-5 · Cited by 336
The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine
Podda, A. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00499-0 · Cited by 333
Aluminum Hydroxide Adjuvants Activate Caspase-1 and Induce IL-1β and IL-18 Release
Li, H., Nookala, S., & Re, F. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.5271 · Cited by 332
Wille-Reece, U., Flynn, B. J., Loré, K., Koup, R. A., Kedl, R. M., Mattapallil, J. J., Weiss, W. R., Roederer, M., & Seder, R. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507484102 · Cited by 332
Self-citationFritz, J. H., Le Bourhis, L., Sellge, G., Magalhaes, J. G., Fsihi, H., Kufer, T. A., Collins, C., Viala, J., Ferrero, R. L., Girardin, S. E., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.03.009 · Cited by 331
Koh, C., Li, Q., & Liang, J. (2016) · Clinical Virology · doi:10.1128/9781555819439.ch54 · Cited by 321
Trumpfheller, C., Caskey, M., Nchinda, G., Longhi, M. P., Mizenina, O., Huang, Y., Schlesinger, S. J., Colonna, M., & Steinman, R. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711976105 · Cited by 310
Huleatt, J. W., Jacobs, A. R., Tang, J., Desai, P., Kopp, E. B., Huang, Y., Song, L., Nakaar, V., & Powell, T. J. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.08.013 · Cited by 299
MF59 Design and Evaluation of a Safe and Potent Adjuvant for Human Vaccines
Ott, G., Barchfeld, G. L., Chernoff, D., Radhakrishnan, R., van Hoogevest, P., & Van Nest, G. (1995) · Pharmaceutical Biotechnology · doi:10.1007/978-1-4615-1823-5_10 · Cited by 298
The DNA Sugar Backbone 2′ Deoxyribose Determines Toll-like Receptor 9 Activation
Haas, T., Metzger, J., Schmitz, F., Heit, A., Müller, T., Latz, E., & Wagner, H. (2008) · Immunity · doi:10.1016/j.immuni.2008.01.013 · Cited by 298
Antonelli, L. R. V., Gigliotti Rothfuchs, A., Gonçalves, R., Roffê, E., Cheever, A. W., Bafica, A., Salazar, A. M., Feng, C. G., & Sher, A. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40817 · Cited by 292
Self-citationLoré, K., Betts, M. R., Brenchley, J. M., Kuruppu, J., Khojasteh, S., Perfetto, S., Roederer, M., Seder, R. A., & Koup, R. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.8.4320 · Cited by 291
Self-citationZandman-Goddard, G., Shoenfeld, Y., Zandman-Goddard, G., & Shoenfeld, Y. (2005) · Autoimmunity · doi:10.1080/08916930500285352 · Cited by 284
Wille-Reece, U., Flynn, B. J., Loré, K., Koup, R. A., Miles, A. P., Saul, A., Kedl, R. M., Mattapallil, J. J., Weiss, W. R., Roederer, M., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052433 · Cited by 275
Self-citationThe path to a successful vaccine adjuvant – ‘The long and winding road’
O’Hagan, D. T., & De Gregorio, E. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.02.009 · Cited by 274
A Modified Polyriboinosinic-Polyribocytidylic Acid Complex That Induces Interferon in Primates
Levy, H. B., Baer, G., Baron, S., Buckler, C. E., Gibbs, C. J., Iadarola, M. J., London, W. T., & Rice, J. (1975) · Journal of Infectious Diseases · doi:10.1093/infdis/132.4.434 · Cited by 270
Khurana, S., Chearwae, W., Castellino, F., Manischewitz, J., King, L. R., Honorkiewicz, A., Rock, M. T., Edwards, K. M., Del Giudice, G., Rappuoli, R., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000624 · Cited by 268
How Do Adjuvants Work? Important Considerations for New Generation Adjuvants
McKee, A. S., Munks, M. W., & Marrack, P. (2007) · Immunity · doi:10.1016/j.immuni.2007.11.003 · Cited by 263
Galli, G., Hancock, K., Hoschler, K., DeVos, J., Praus, M., Bardelli, M., Malzone, C., Castellino, F., Gentile, C., McNally, T., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903181106 · Cited by 263
Galli, G., Medini, D., Borgogni, E., Zedda, L., Bardelli, M., Malzone, C., Nuti, S., Tavarini, S., Sammicheli, C., Hilbert, A. K., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813390106 · Cited by 261
Vaccination in the elderly: an immunological perspective
Chen, W. H., Kozlovsky, B. F., Effros, R. B., Grubeck-Loebenstein, B., Edelman, R., & Sztein, M. B. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.05.002 · Cited by 228
Vandepapelière, P., Horsmans, Y., Moris, P., Van Mechelen, M., Janssens, M., Koutsoukos, M., Van Belle, P., Clement, F., Hanon, E., Wettendorff, M., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2007.12.038 · Cited by 218
McCartney, S., Vermi, W., Gilfillan, S., Cella, M., Murphy, T. L., Schreiber, R. D., Murphy, K. M., & Colonna, M. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20091181 · Cited by 216
Stahl-Hennig, C., Eisenblätter, M., Jasny, E., Rzehak, T., Tenner-Racz, K., Trumpfheller, C., Salazar, A. M., Überla, K., Nieto, K., Kleinschmidt, J., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000373 · Cited by 198
Banzhoff, A., Gasparini, R., Laghi-Pasini, F., Staniscia, T., Durando, P., Montomoli, E., Capecchi, P., di Giovanni, P., Sticchi, L., Gentile, C., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004384 · Cited by 194
Sensing and Signaling in Antiviral Innate Immunity
O'Neill, L. A. J., & Bowie, A. G. (2010) · Current Biology · doi:10.1016/j.cub.2010.01.044 · Cited by 186
Dendritic Cells Internalize Vaccine Adjuvant after Intramuscular Injection
Dupuis, M., Murphy, T. J., Higgins, D., Ugozzoli, M., van Nest, G., Ott, G., & McDonald, D. M. (1998) · Cellular Immunology · doi:10.1006/cimm.1998.1283 · Cited by 185
A West Nile Virus Recombinant Protein Vaccine That Coactivates Innate and Adaptive Immunity
McDonald, W. F., Huleatt, J. W., Foellmer, H. G., Hewitt, D., Tang, J., Desai, P., Price, A., Jacobs, A., Takahashi, V. N., Huang, Y., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/517613 · Cited by 185
Pellegrini, M., Nicolay, U., Lindert, K., Groth, N., & Della Cioppa, G. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.08.101 · Cited by 183
Verstraeten, T., Descamps, D., David, M., Zahaf, T., Hardt, K., Izurieta, P., Dubin, G. O., & Breuer, T. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.09.049 · Cited by 155
Immunodrugs: Therapeutic VLP-Based Vaccines for Chronic Diseases
Jennings, G. T., & Bachmann, M. F. (2008) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-061008-103129 · Cited by 138
Su, S. B., Silver, P. B., Grajewski, R. S., Agarwal, R. K., Tang, J., Chan, C., & Caspi, R. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6303 · Cited by 136
Halperin, S. A., Dobson, S., McNeil, S., Langley, J. M., Smith, B. R., McCall-Sani, R., Levitt, D., Nest, G. V., Gennevois, D., & Eiden, J. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.08.095 · Cited by 134
Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data
Moorthy, V., & Ballou, W. R. (2009) · Malaria Journal · doi:10.1186/1475-2875-8-312 · Cited by 134
Immune mechanisms of protection: can adjuvants rise to the challenge?
McKee, A. S., MacLeod, M. K. L., Kappler, J. W., & Marrack, P. (2010) · BMC Biology · doi:10.1186/1741-7007-8-37 · Cited by 120
Gowen, B. B., Wong, M., Jung, K., Sanders, A. B., Mitchell, W. M., Alexopoulou, L., Flavell, R. A., & Sidwell, R. W. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.5200 · Cited by 116
Heit, A., Maurer, T., Hochrein, H., Bauer, S., Huster, K. M., Busch, D. H., & Wagner, H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.2802 · Cited by 110
Schnurr, M. M., Orban, M., Robson, N. C., Shin, A., Braley, H., Airey, D., Cebon, J. S., Maraskovsky, E., & Endres, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1253 · Cited by 108
Vaccine Adjuvants Alter TCR-Based Selection Thresholds
Malherbe, L. P., Mark, L., Fazilleau, N., McHeyzer‐Williams, L. J., & McHeyzer‐Williams, M. G. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.014 · Cited by 106
Immunotherapeutic activity of a conjugate of a Toll-like receptor 7 ligand
Wu, C. C. N., Hayashi, T., Takabayashi, K., Sabet, M., Smee, D. F., Guiney, D. D., Cottam, H. B., & Carson, D. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611624104 · Cited by 106
Davey, G. M., Wojtasiak, M., Proietto, A. I., Carbone, F., Heath, W. R., & Bedoui, S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903013 · Cited by 103
Immunostimulatory DNA Prepriming: A Novel Approach for Prolonged Th1-Biased Immunity
Kobayashi, H., Horner, A. A., Takabayashi, K., Nguyen, M.-D., Huang, E., Cinman, N., & Raz, E. (1999) · Cellular Immunology · doi:10.1006/cimm.1999.1572 · Cited by 94
Wang, Y., Cella, M., Gilfillan, S., & Colonna, M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903201 · Cited by 93
Immunostimulatory activity of haptenated proteins
Palm, N. W., & Medzhitov, R. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809403105 · Cited by 84
Innate Immune Detection of Bacterial Virulence Factors Via the NLRC4 Inflammasome
Miao, E. A., & Warren, S. E. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9386-5 · Cited by 73
Campbell, J. D., Cho, Y., Foster, M. L., Kanzler, H., Kachura, M. A., Lum, J. A., Ratcliffe, M., Sathe, A., Leishman, A. J., Bahl, A. K., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38294 · Cited by 72
Self-citationBoth Radioresistant and Hemopoietic Cells Promote Innate and Adaptive Immune Responses to Flagellin
Sanders, C. J., Moore, D. A., Williams, I. R., & Gewirtz, A. T. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7184 · Cited by 55
Serre, K., Mohr, E., Toellner, K., Cunningham, A. F., Granjeaud, S., Bird, R., & MacLennan, I. C. M. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.05.010 · Cited by 48
Gram, G. J., Karlsson, I., Agger, E. M., Andersen, P. L., & Fomsgaard, A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006950 · Cited by 45
Modulation of adaptive immunity by different adjuvant–antigen combinations in mice lacking Nod2
Moreira, L. O., Smith, A. M., DeFreitas, A. A., Qualls, J. E., Kasmi, K. C. E., & Murray, P. J. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.08.038 · Cited by 43
Polymyxin B enhances ISS-mediated immune responses across multiple species
Marshall, J. D., Higgins, D., Abbate, C., Yee, P., Teshima, G. M., Ott, G. S., Cruz, T. D., Passmore, D., Fearon, K. L., Tuck, S., et al. (2004) · Cellular Immunology · doi:10.1016/j.cellimm.2004.04.009 · Cited by 27
Teleshova, N., Kenney, J., Nest, G. V., Marshall, J. D., Lifson, J. D., Sivin, I., Dufour, J., Bohm, R. P., Gettie, A., & Robbiani, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8531 · Cited by 19
Cited by
Emerging concepts in the science of vaccine adjuvants
Pulendran, B., S. Arunachalam, P., & O’Hagan, D. T. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00163-y · Cited by 1,385
M1 and M2 Macrophages: Oracles of Health and Disease
Mills, C. (2012) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v32.i6.10 · Cited by 1,141
Immunological mechanisms of vaccination
Pulendran, B., & Ahmed, R. (2011) · Nature Immunology · doi:10.1038/ni.2039 · Cited by 1,089
Vaccine adjuvants: mechanisms and platforms
Zhao, T., Cai, Y., Jiang, Y., He, X., Wei, Y., Yu, Y., & Tian, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01557-7 · Cited by 1,020
Modified mRNA vaccines protect against zika virus infection
Richner, J. M., Himansu, S., Dowd, K. A., Butler, S. L., Salazar, V., Fox, J. M., Julander, J. G., Tang, W. W., Shresta, S., Pierson, T. C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.02.017 · Cited by 909
Metadata
- Authors
- Coffman, R. L., Sher, A., & Seder, R. A.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2010-10
- Volume
- 33
- Issue
- 4
- Pages
- 492-503
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2144887013
- Cited by
- 1,924
- References
- 112
- FWCI
- 32.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.